Lipid-Polyglutamate Nanoparticle Vaccine Platform.
Quick Facts
What This Study Found
PGA-based lipid nanoparticles co-delivering peptide antigen and TLR7/8 agonist activated antigen-specific T cells in mice via both subcutaneous and IV routes.
Key Numbers
PGA-Ag + PGA-IMDQ co-delivered; ionizable lipid LNP; SC and IV routes; innate immune cell uptake confirmed; Ag-specific T cells induced
How They Did This
Lab and animal study. Conjugated peptide antigen and IMDQ adjuvant to PGA. Condensed into lipid nanoparticles with ionizable lipid. Tested uptake by immune cells and T-cell activation in mouse models.
Why This Research Matters
A universal platform for co-delivering any peptide antigen with immune boosters could accelerate personalized cancer vaccine development.
What This Study Doesn't Tell Us
Animal study in mice. Efficacy against actual tumors not tested. Human immune responses may differ. Specific peptide antigens tested were limited.
Trust & Context
- Original Title:
- Lipid-Polyglutamate Nanoparticle Vaccine Platform.
- Published In:
- ACS applied materials & interfaces, 13(5), 6011-6022 (2021)
- Authors:
- Van Lysebetten, Dorien, Malfanti, Alessio, Deswarte, Kim, Koynov, Kaloian, Golba, Bianka, Ye, Tingting, Zhong, Zifu, Kasmi, Sabah, Lamoot, Alexander, Chen, Yong, Van Herck, Simon, Lambrecht, Bart N, Sanders, Niek N, Lienenklaus, Stefan, David, Sunil A, Vicent, María J, De Koker, Stefaan, De Geest, Bruno G
- Database ID:
- RPEP-05838
Evidence Hierarchy
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05838APA
Van Lysebetten, Dorien; Malfanti, Alessio; Deswarte, Kim; Koynov, Kaloian; Golba, Bianka; Ye, Tingting; Zhong, Zifu; Kasmi, Sabah; Lamoot, Alexander; Chen, Yong; Van Herck, Simon; Lambrecht, Bart N; Sanders, Niek N; Lienenklaus, Stefan; David, Sunil A; Vicent, María J; De Koker, Stefaan; De Geest, Bruno G. (2021). Lipid-Polyglutamate Nanoparticle Vaccine Platform.. ACS applied materials & interfaces, 13(5), 6011-6022. https://doi.org/10.1021/acsami.0c20607
MLA
Van Lysebetten, Dorien, et al. "Lipid-Polyglutamate Nanoparticle Vaccine Platform.." ACS applied materials & interfaces, 2021. https://doi.org/10.1021/acsami.0c20607
RethinkPeptides
RethinkPeptides Research Database. "Lipid-Polyglutamate Nanoparticle Vaccine Platform." RPEP-05838. Retrieved from https://rethinkpeptides.com/research/van-2021-lipidpolyglutamate-nanoparticle-vaccine-platform
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.